US Pharma and Biotech Summit 2024: Improving Health Policy After the 2024 Election
May 22nd 2024In an interview with Pharm Exec Associate Editor Don Tracy, Robert Zirkelback, Chief Public Affairs Officer, Head of Strategic Initiatives, PhRMA discusses best-case scenarios for health policy amid the 2024 presidential election.
US Pharma and Biotech Summit 2024: Bringing the Skillset of Generation Alpha to the Pharma Industry
May 22nd 2024In an interview with Pharm Exec Associate Editor Don Tracy, Carmen Villar, VP, ESG & Corporate Citizenship, Gilead Sciences discusses new skills that members of generation Alpha will bring to the pharma industry and potential struggles that they may face.
US Pharma and Biotech Summit 2024: The 2024 Presidential Election and the Pharma Industry
May 20th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Robert Zirkelback, Chief Public Affairs Officer, Head of Strategic Initiatives, PhRMA discusses the upcoming United States presidential election and the potential impact that it could have on the pharma industry.